Clinical trial
A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
NCT05172726 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
- Lead sponsor
- Organon and Co
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- December 2, 2021
- Completion date
- October 31, 2026
- Enrollment
- 58 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
plaque psoriasis